PHARMAPROMO.com LAUNCHES 3 UNIQUE ADVERTISING SOLUTIONS TO PROMOTE GENERIC DRUGS ON THE INTERNET.

Richard Cottrell, responsible for PharmaPromo.com’s corporate marketing & business development, stated: “these tailor-made packages are unique because they focus on providing a complimentary solution to business, marketing and partnering strategies. We decided to slash our advertising costs and offer small-to-medium sized pharma companies an opportunity to capitalize on the success of our network and present them with an alternative resource for expanding their corporate objectives”. These packages focus on two distinct levels: to develop brand awareness and patient loyalty via its highly-targeted customer base; and provide pharmaceutical companies from all sectors (manufacturing, distribution, healthcare, PBMs, medical consultancy and research organizations) the opportunity to develop their global online presence and strengthen their brand recognition.

The success of PharmaPromo.com is primarily due to the fact that each individual site focuses specifically and exclusively on one medication, such as Fluoxetine.com (Prozac), Lisinopril.com (Zestril), Atorvastatin.com (Lipitor), Fexofenadine.com (Allegra), Lansoprazole.com (Prevacid), etc… From a consumer’s viewpoint, finding reliable information on a leading prescription or OTC medication can be a stressful experience. Jean-Paul Andrivet, Managing Director, highlighted that, “…we are unique in that our network of sites offer a one-stop reference point where patients, doctors, and pharmacists can access reliable and updated information on these drugs and their manufacturers. Moreover, they can consult crucial facts on symptoms, dosage and other product information including the latest product and R&D news, an image library and an interactive forum”.

From a corporate prospective, the generics market is undergoing significant transformation and the fight for consumer share and attaining a solid competitive edge has never been so disputed. PharmaPromo.com offers pharma companies a fully-focused association with the generic drug(s) of their choice, providing a perfect platform to compliment product portfolios and keeping consumers and business partners updated on new product launches and corporate activities. “Our existing clients believe that partnering with us has given them an opportunity to establish a long-term strategic advantage in the face of their competitors, and has successfully consolidating future online business partnerships”, stated Richard Cottrell.

The increasing demand for cheaper generic medications, new government legislations in favor of lowering costs for consumers and healthcare organizations, and the loss of patent on blockbuster drugs has not only meant that generic drugs are more readily available but its affect has also been noticed in the way doctors and pharmacists write out their prescriptions. These factors are a clear indication that the generics sector will account for almost 60% of total prescriptions in the US by 2008.